The study discussing SNS vs UPI's device appears to be InterStim by Medtronic. MDT is a mighty foe to beat, even if you have as good, and more cost effective product. Let's hope they can pull it off long term. Maybe Medicare will reject the higher cost product! UPI has given the impression they have very good patent protection, lets hope that is true.